Learn more about whether Moderna, Inc. or Twist Bioscience Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

JPMorgan Chase & Co. decreased its holdings in Twist Bioscience Co. (NASDAQ:TWST – Free Report) by 27.3% during the fourth ...

Biopharmaceuticals represent another significant market segment, holding a dominant share of 44.2%. The increasing emphasis on biologics, gene therapies, and personalized medicine is fueling the ...

Circio and Entos have initiated a research collaboration that will involve joint development and in vivo delivery testing of ...

PLC (AIM: 4BB) (“4basebio”), a company which develops and commercializes the large-scale manufacture of synthetic DNA as well as nanoparticle delivery solutions, today announced that it has received ...

IDT and Elegen partner to launch an early access program offering long, clonal gene synthesis and high-complexity genes up to ...

The Global DNA Data Storage Market Size is projected to grow at a CAGR of 74.48% from 2026 to 2032, according to a new report published by Verified Market Research®. The report reveals that the market ...

Teacher Retirement System of Texas boosted its holdings in Twist Bioscience Co. (NASDAQ:TWST – Free Report) by 18.9% in the 4th quarter, according to its most recent filing with the Securities and ...

The direct-to-consumer DNA testing service 23andMe filed for bankruptcy earlier this month, putting millions of customers' ...

Its DNA sequencing technology is based on its reversible terminator-based sequencing chemistry, known as sequencing by ...